Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  13,066 results for ""Pleural Neoplasms""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Extensive surgical resections for rare pleural neoplasms: a single-center experience with a yolk sac tumor and synovial sarcoma.

  • Authors : Vandaele T; Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium. .; Department of Chronic Diseases and Metabolism, Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), KU Leuven, Leuven, Belgium. .

Subjects: Sarcoma, Synovial*/Sarcoma, Synovial*/Sarcoma, Synovial*/surgery ; Endodermal Sinus Tumor*/Endodermal Sinus Tumor*/Endodermal Sinus Tumor*/surgery ; Pleural Neoplasms*/Pleural Neoplasms*/Pleural Neoplasms*/surgery

  • Source: World journal of surgical oncology [World J Surg Oncol] 2024 Apr 16; Vol. 22 (1), pp. 96. Date of Electronic Publication: 2024 Apr 16.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

Record details

Read More Add to Saved list
×
Academic Journal

Ovarian cancer deaths attributable to asbestos exposure in Lombardy (Italy) in 2000-2018.

  • Authors : Stoppa G; Unit of Biostatistics, Epidemiology and Public Health, DCTVPH, University of Padua, Padova, Italy .; Mensi C

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/mortality ; Asbestos*/Asbestos*/Asbestos*/adverse effects ; Bayes Theorem*

  • Source: Occupational and environmental medicine [Occup Environ Med] 2024 Aug 16; Vol. 81 (7), pp. 359-365. Date of Electronic Publication: 2024 Aug 16.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 9422759 Publication Model: Electronic Cited Medium: Internet ISSN: 1470-7926

Record details

Read More Add to Saved list
×
Academic Journal

Exposure to fibres and risk of pleural mesothelioma in the Norwegian Offshore Petroleum Workers cohort.

  • Authors : Berge LAM; Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway .; Department of Research, Cancer Registry of Norway, National Institute of Public Health, Oslo, Norway.

Subjects: Occupational Exposure*/Occupational Exposure*/Occupational Exposure*/adverse effects ; Asbestos*/Asbestos*/Asbestos*/adverse effects ; Mesothelioma*/Mesothelioma*/Mesothelioma*/epidemiology

  • Source: Occupational and environmental medicine [Occup Environ Med] 2024 Aug 16; Vol. 81 (7), pp. 331-338. Date of Electronic Publication: 2024 Aug 16.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 9422759 Publication Model: Electronic Cited Medium: Internet ISSN: 1470-7926

Record details

Read More Add to Saved list
×
Academic Journal

Complete response in a lung adenocarcinoma with pleural metastases initially treated with gefitinib and switched to osimertinib after cerebral oligo-progression with unknown T790M mutation: a case report and review of literature.

  • Authors : Hachlaf M; Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco. .; Lkhoyaali S

Subjects: Aniline Compounds*/Aniline Compounds*/Aniline Compounds*/therapeutic use ; Acrylamides*/Acrylamides*/Acrylamides*/therapeutic use ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy

  • Source: Journal of medical case reports [J Med Case Rep] 2024 Aug 08; Vol. 18 (1), pp. 374. Date of Electronic Publication: 2024 Aug 08.Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium: Internet ISSN: 1752-1947

Record details

Read More Add to Saved list
×
Academic Journal

Patient characteristics, treatment patterns, and survival outcomes for patients with malignant pleural mesothelioma in Denmark between 2011 and 2018: a nationwide population-based cohort study.

  • Authors : Sørensen JB; Department of Oncology, Rigshospitalet, Copenhagen, Denmark. .; Baas P

Subjects: Mesothelioma, Malignant*/Mesothelioma, Malignant*/Mesothelioma, Malignant*/therapy ; Mesothelioma, Malignant*/Mesothelioma, Malignant*/Mesothelioma, Malignant*/mortality ; Mesothelioma, Malignant*/Mesothelioma, Malignant*/Mesothelioma, Malignant*/pathology

  • Source: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 Aug 08; Vol. 63, pp. 649-657. Date of Electronic Publication: 2024 Aug 08.Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Connect Read More Add to Saved list
×
Academic Journal

Chemotherapy increases CDA expression and sensitizes malignant pleural mesothelioma cells to capecitabine treatment.

  • Authors : Karatkevich D; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Murtenstrasse 28, 3008, Bern, Switzerland.; Oncology-Thoracic Malignancies, Department for BioMedical Research, University of Bern, Bern, Switzerland.

Subjects: Capecitabine*/Capecitabine*/Capecitabine*/pharmacology ; Mesothelioma, Malignant*/Mesothelioma, Malignant*/Mesothelioma, Malignant*/drug therapy ; Mesothelioma, Malignant*/Mesothelioma, Malignant*/Mesothelioma, Malignant*/metabolism

  • Source: Scientific reports [Sci Rep] 2024 Aug 06; Vol. 14 (1), pp. 18206. Date of Electronic Publication: 2024 Aug 06.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comparison of First-Line Chemotherapeutics and Validation of the EORTC Prognostic Index in Malignant Pleural Mesothelioma: Retrospective Single-Centre Experience.

  • Authors : Sezgin Y; Department of Medical Oncology, Van Yuzuncu Yil University, Van, Turkiye.; Department of Medical Oncology, Harran University, Sanliurfa, Turkiye.

Subjects: Pemetrexed*/Pemetrexed*/Pemetrexed*/therapeutic use ; Pemetrexed*/Pemetrexed*/Pemetrexed*/administration & dosage ; Cisplatin*/Cisplatin*/Cisplatin*/therapeutic use

  • Source: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP [J Coll Physicians Surg Pak] 2024 Aug; Vol. 34 (8), pp. 904-909.Publisher: College of Physicians and Surgeons Pakistan Country of Publication: Pakistan NLM ID: 9606447 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

CT-guided needle biopsy is not associated with increased ipsilateral pleural metastasis.

  • Authors : Niedermaier B; Department of Thoracic Surgery, Thoraxklinik at the University of Heidelberg, Heidelberg, Germany; Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research, Heidelberg, Germany. Electronic address: .

Subjects: Pleural Neoplasms*/Pleural Neoplasms*/Pleural Neoplasms*/secondary ; Pleural Neoplasms*/Pleural Neoplasms*/Pleural Neoplasms*/pathology ; Pleural Neoplasms*/Pleural Neoplasms*/Pleural Neoplasms*/diagnostic imaging

  • Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Aug; Vol. 194, pp. 107890. Date of Electronic Publication: 2024 Jul 14.Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Spatial Landscape of Malignant Pleural and Peritoneal Mesothelioma Tumor Immune Microenvironments.

  • Authors : Ma X; UPMC Hillman Cancer Center, Cancer Biology Program, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Lembersky D

Subjects: Tumor Microenvironment*/Tumor Microenvironment*/Tumor Microenvironment*/immunology ; Mesothelioma, Malignant*/Mesothelioma, Malignant*/Mesothelioma, Malignant*/immunology ; Mesothelioma, Malignant*/Mesothelioma, Malignant*/Mesothelioma, Malignant*/pathology

  • Source: Cancer research communications [Cancer Res Commun] 2024 Aug 01; Vol. 4 (8), pp. 2133-2146.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04-2021) trial.

Subjects: Nivolumab*/Nivolumab*/Nivolumab*/administration & dosage ; Nivolumab*/Nivolumab*/Nivolumab*/therapeutic use ; Nivolumab*/Nivolumab*/Nivolumab*/adverse effects

  • Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Aug; Vol. 194, pp. 107866. Date of Electronic Publication: 2024 Jun 29.Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  13,066 results for ""Pleural Neoplasms""